» Articles » PMID: 38993475

Changes in the Quality of Life and Nutrition Markers in Transition From End-Stage Kidney Disease to Kidney Transplantation: Insights From a Vietnamese Cohort

Overview
Journal Cureus
Date 2024 Jul 12
PMID 38993475
Authors
Affiliations
Soon will be listed here.
Abstract

Background Malnutrition is strongly associated with lower quality of life (QoL) and lower survival rates in patients with end-stage kidney disease. However, the impact of renal transplantation on nutrition factors and QoL is unclear. Therefore, this study aims to assess changes in QoL and investigate the relationships with nutrition factors among kidney transplant recipients (KTRs). Materials and methods A longitudinal study included 86 dialysis patients aged 18-65 years who underwent primary kidney transplantation (KTx) and were followed up for one year. Body weight, biochemical parameters, and QoL data were collected before transplantation (T0) and at six months (T6) and 12 months (T12) post-transplantation. Effect size (ES) was used to measure the impact of KTx on QoL and nutritional status from T0 to T12. The predictors of QoL were calculated with β-coefficients and p<0.05 in linear regression. Results The ES of transplantation on the QoL of KTRs was large, at 1.1 for health change, 0.9 for physical health, and moderate (0.7) for mental health (MH) over one year. Hemoglobin and malnourished were affected by KTx, with ES being 2.4 and 0.6, respectively. Linear regression showed that physical health was predicted by hemoglobin (β=0.12, p<0.01), phosphorus (β=7.82, p<0.05), and dose of mycophenolate mofetil (MMF) (β=-0.01, p<0.05). Mental health was predicted by obesity (β=-7.63, p<0.05), hemoglobin (β=0.11, p<0.05), and phosphorus (β=8.49, p<0.01). Health change was indicated by nutritional risk index (NRI) score (β=0.47, p<0.05), total cholesterol (β=3.39, p<0.01), and kidney function (β=0.15, p<0.05). Conclusions The transition from end-stage kidney disease to transplantation has positive impacts on QoL and nutrition markers. Nutritional status, kidney function, and the dose of mycophenolate mofetil are significant determinants of QoL in KTRs.

References
1.
Russcher M, Nagtegaal J, Nurmohamed S, Koch B, van der Westerlaken M, van Someren E . The effects of kidney transplantation on sleep, melatonin, circadian rhythm and quality of life in kidney transplant recipients and living donors. Nephron. 2014; 129(1):6-15. DOI: 10.1159/000369308. View

2.
Iqbal M, Rahman N, Alam M, Deb Nath P, Waheed S, Islam K . Quality of Life Is Improved in Renal Transplant Recipients Versus That Shown in Patients With Chronic Kidney Disease With or Without Dialysis. Exp Clin Transplant. 2020; 18(Suppl 1):64-67. DOI: 10.6002/ect.TOND-TDTD2019.P11. View

3.
Vu L, Nghia N, Tuan T, Phuong T, Vo H, Viet K . Measuring Health-Related Quality of Life in Vietnamese Patients After Kidney Transplantation. Front Surg. 2021; 8:646629. PMC: 8418059. DOI: 10.3389/fsurg.2021.646629. View

4.
Alharbi A, Alharbi Y, Alsobhi A, Alharbi M, Alharbi M, Aljohani A . Impact of Illness Perception on the Health-Related Quality of Life of Patients Receiving Dialysis: A Cross-Sectional Study. Cureus. 2021; 13(6):e15705. PMC: 8285669. DOI: 10.7759/cureus.15705. View

5.
Hosohata K, Matsuoka E, Inada A, Oyama S, Niinomi I, Mori Y . Differential profiles of adverse events associated with mycophenolate mofetil between adult and pediatric renal transplant patients. J Int Med Res. 2018; 46(11):4617-4623. PMC: 6259373. DOI: 10.1177/0300060518786917. View